FONR: FONAR EV/EBITDA Multiple

Corporate emblem and logo of FONAR (FONR)

FONAR Corporation is expanding sales of innovative vertical tomographs and opening its own radiology centers to increase its market presence. This chart of the price trend based on the EV/EBITDA metric shows a value of 6.42. Delivering such systems requires the use of complex rigging equipment and reinforced cargo protection, ensuring the perfect preservation of precision mechanisms during transport to clinics.

FONAR Corporation Inc - FONR Enterprise Value to EBITDA Ratio (period 11/23/2025 - 06/13/2026)

Summary analytical data breakdowns for fonar.com (FONR)

- stock price and consensus target price:
Stock Quotes FONAR Corp|FONR - Analyst Forecast Prices
- market capitalization information:
Market Capitalization FONAR Corporation Inc|FONR - Company Buyout Price
- issuer book value statistics:
Book Value per Share FONAR|FONR - Company Net Assets|Market Cap to Net Assets Ratio fonar.com|FONR - Aggregate Asset Value
- company liabilities and liquidity data:
Debt to Equity FONAR Corporation|FONR - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital FONAR|FONR - Company Cumulative Debt|Debts to Book Capitalization FONAR Corporation Inc|FONR - Company Long-Term Indebtedness|Company Short-Term Debts FONAR|Quick Ratio fonar.com
- financial results and valuation multiples details:
FONR - Net Income|Projected Future Earnings FONAR Corporation|FONR - P/E Multiple|Future Price to Earnings FONAR Corporation|FONR - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio FONAR Corporation Inc|FONR - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) FONAR|FONR - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months fonar.com|FONR - Net earnings per share change in current year|Expected earnings per share growth for next year FONAR Corporation
Initial company analysis:FONAR Corp FONR
Original product of fonar.com

The specific nature of producing patented MRI systems with strict FDA certification requires significant capital expenditures, making the business valuation via the EV/EBITDA ratio critical for FONAR Corporation (FONR). This indicator compares the total enterprise value with its operating profit before interest, taxes, depreciation, and amortization, allowing the real value of assets to be determined independently of the debt load through the business's EV/EBITDA multiple history.

Competitor analysis for FONAR Corporation

Abbott Laboratories Inc. - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio TMO (Thermo Scientific)|GE HealthCare - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio mt.com MTD|WAT: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Bio-Techne Corp|Enterprise Value to EBITDA Ratio BRKR|AZTA: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Varex Imaging (VREX)|Enterprise Value to EBITDA Ratio semlerscientific.com SMLR|EV/EBITDA Multiple BFLY (Butterfly Network)|Mesa Laboratories Inc (MLAB) - Company Value to EBITDA|Quantum-Si Corp - EV/EBITDA Multiple|NNOX (Nano-X Imaging Ltd) - Enterprise Value to Operating Income Before Depreciation|QTRX: EV/EBITDA Multiple|MASS - Total Company Value to Operating Income Before Depreciation Ratio|CV (CapsoVision, Inc.) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio MaxCyte Inc. (MXCT)|EV/EBITDA Multiple RPID|EV/EBITDA Multiple Seer Bio (SEER)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Hyperfine, Inc. HYPR|Daxor Corp - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|MDAI: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation VIVS (Organovo Holdings)|ACON: EV/EBITDA Multiple|Company Value to EBITDA Akoya Biosciences, Inc. (AKYA)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ThermoGenesis|TLIS - Enterprise Value to EBITDA Multiple|Enterprise Value to EBITDA Ratio TTOO (T2 Biosystems)